A carregar...

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

The proliferation index in mantle cell lymphoma (MCL) has not been validated in the context of aggressive therapy regimens in the rituximab era. We assessed Ki67 and PIM1 (a cell cycle-related gene upregulated in blastoid MCL) expression by immunohistochemistry in a phase II study Cancer and Leukemi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: HSI, ERIC D., JUNG, SIN-HO, LAI, RAYMOND, JOHNSON, JEFFREY L., COOK, JAMES R., JONES, DAN, DEVOS, SVEN, CHESON, BRUCE D., DAMON, LLOYD E., SAID, JONATHAN
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4011712/
https://ncbi.nlm.nih.gov/pubmed/19021050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428190802419640
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!